These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 31278243)

  • 1. Problems Associated With Some Drug Formulations.
    Paul Y
    Indian Pediatr; 2019 Jun; 56(6):513-514. PubMed ID: 31278243
    [No Abstract]   [Full Text] [Related]  

  • 2. [Quality control in the pharmaceutical industry].
    Sloot HA
    Pharm Weekbl; 1968 Apr; 103(17):506-16. PubMed ID: 5665061
    [No Abstract]   [Full Text] [Related]  

  • 3. Current good manufacturing practice regulations.
    Bumiller J
    Bull Parenter Drug Assoc; 1971; 25(5):222-5. PubMed ID: 5094094
    [No Abstract]   [Full Text] [Related]  

  • 4. Overview of the parenteral nutrition use process.
    Boullata JI
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):10S-13S. PubMed ID: 22275321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of safe practices for parenteral nutrition formulations. American Society Parenteral and Enteral Nutrition.
    Kumpf VJ
    Am J Health Syst Pharm; 1999 Apr; 56(8):815-7. PubMed ID: 10326617
    [No Abstract]   [Full Text] [Related]  

  • 6. Changing over-the-counter drugs while retaining the brand name.
    Merikangas JR
    Ann Intern Med; 1993 Jun; 118(12):988. PubMed ID: 8489122
    [No Abstract]   [Full Text] [Related]  

  • 7. Compounding vs standardized commercial parenteral nutrition product: pros and cons.
    Gervasio J
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):40S-41S. PubMed ID: 22301324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiopharmaceutical production--radiation safety.
    Fredrickson RL; Myers CB
    IMS Ind Med Surg; 1969 Jul; 38(7):199-204. PubMed ID: 5256328
    [No Abstract]   [Full Text] [Related]  

  • 9. New Jersey standards affect dispensing of i.v. admixtures.
    Polillo PC; Ferri L
    Am J Hosp Pharm; 1987 Nov; 44(11):2486-7. PubMed ID: 3687980
    [No Abstract]   [Full Text] [Related]  

  • 10. Response.
    Guharoy R; Noviasky J; Haydar Z; Fakih MG; Hartman C
    Chest; 2013 Aug; 144(2):717-718. PubMed ID: 23918133
    [No Abstract]   [Full Text] [Related]  

  • 11. Need for specific-gravity values in adopting gravimetric measurement in sterile compounding.
    Roberts PA; Valgus JM; Willoughby IR; Amerine LB
    Am J Health Syst Pharm; 2017 Jun; 74(12):871-872. PubMed ID: 28596223
    [No Abstract]   [Full Text] [Related]  

  • 12. Errors discovered in a manufacturing program.
    Das Gupta V
    Am J Hosp Pharm; 1973 Feb; 30(2):112. PubMed ID: 4690464
    [No Abstract]   [Full Text] [Related]  

  • 13. GMPs vs GCPs: manufacturing and compounding definitions.
    Allen LV
    Int J Pharm Compd; 2013; 17(5):356. PubMed ID: 24459778
    [No Abstract]   [Full Text] [Related]  

  • 14. When pharmacies cause harm.
    Jha VM
    Chest; 2013 Aug; 144(2):717. PubMed ID: 23918132
    [No Abstract]   [Full Text] [Related]  

  • 15. Labeling and record keeping for compounded drugs.
    Ballitch EJ
    J Am Vet Med Assoc; 1994 Jul; 205(2):249-50. PubMed ID: 7928591
    [No Abstract]   [Full Text] [Related]  

  • 16. For U.S. drug companies' products sold in developing countries, labeling is often inadequate.
    Am J Hosp Pharm; 1994 Apr; 51(7):875-6. PubMed ID: 8017435
    [No Abstract]   [Full Text] [Related]  

  • 17. Issues surrounding compounding of parenteral nutrition.
    Robinson LA
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):36S-37S. PubMed ID: 22275324
    [No Abstract]   [Full Text] [Related]  

  • 18. Compounding pharmacy conundrum: "we cannot live without them but we cannot live with them" according to the present paradigm.
    Guharoy R; Noviasky J; Haydar Z; Fakih MG; Hartman C
    Chest; 2013 Apr; 143(4):896-900. PubMed ID: 23412546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Panel discussion: in process control and inspection for quality assurance. 3.
    Brofazi FR
    Bull Parenter Drug Assoc; 1968; 22(2):90-6. PubMed ID: 5649572
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug promotion: stealth, wealth, and safety.
    Lancet; 1993 Jun; 341(8859):1507-8. PubMed ID: 8099382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.